Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
- PMID:32695833
- PMCID: PMC7368938
- DOI: 10.1155/2020/7201752
Protective Immunity against SARS Subunit Vaccine Candidates Based on Spike Protein: Lessons for Coronavirus Vaccine Development
Abstract
The recent outbreak of the novel coronavirus disease, COVID-19, has highlighted the threat that highly pathogenic coronaviruses have on global health security and the imminent need to design an effective vaccine for prevention purposes. Although several attempts have been made to develop vaccines against human coronavirus infections since the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) in 2003, there is no available licensed vaccine yet. A better understanding of previous coronavirus vaccine studies may help to design a vaccine for the newly emerged virus, SARS-CoV-2, that may also cover other pathogenic coronaviruses as a potentially universal vaccine. In general, coronavirus spike protein is the major antigen for the vaccine design as it can induce neutralizing antibodies and protective immunity. By considering the high genetic similarity between SARS-CoV and SARS-CoV-2, here, protective immunity against SARS-CoV spike subunit vaccine candidates in animal models has been reviewed to gain advances that can facilitate coronavirus vaccine development in the near future.
Copyright © 2020 Atin Khalaj-Hedayati.
Conflict of interest statement
There is no conflict of interest.
Figures
Similar articles
- A systematic review of SARS-CoV-2 vaccine candidates.Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F.Dong Y, et al.Signal Transduct Target Ther. 2020 Oct 13;5(1):237. doi: 10.1038/s41392-020-00352-y.Signal Transduct Target Ther. 2020.PMID:33051445Free PMC article.
- SARS-CoV-2: A New Song Recalls an Old Melody.Subbarao K.Subbarao K.Cell Host Microbe. 2020 May 13;27(5):692-694. doi: 10.1016/j.chom.2020.04.019.Cell Host Microbe. 2020.PMID:32407706Free PMC article.Review.
- Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.Chen WH, Tao X, Agrawal AS, Algaissi A, Peng BH, Pollet J, Strych U, Bottazzi ME, Hotez PJ, Lustigman S, Du L, Jiang S, Tseng CK.Chen WH, et al.Vaccine. 2020 Nov 3;38(47):7533-7541. doi: 10.1016/j.vaccine.2020.09.061. Epub 2020 Sep 22.Vaccine. 2020.PMID:33039209Free PMC article.
- Developing a low-cost and accessible COVID-19 vaccine for global health.Hotez PJ, Bottazzi ME.Hotez PJ, et al.PLoS Negl Trop Dis. 2020 Jul 29;14(7):e0008548. doi: 10.1371/journal.pntd.0008548. eCollection 2020 Jul.PLoS Negl Trop Dis. 2020.PMID:32726304Free PMC article.No abstract available.
- SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.De León-Rodríguez SG, Hernández-Rico B, Olmo-Vázquez GD, Cruz-Dávalos I, Bonifaz LC.De León-Rodríguez SG, et al.Bol Med Hosp Infant Mex. 2020;77(5):252-261. doi: 10.24875/BMHIM.20000191.Bol Med Hosp Infant Mex. 2020.PMID:33064679Review.English.
Cited by
- Characterization of two linear epitopes SARS CoV-2 spike protein formulated in tandem repeat.Tarigan S, Dharmayanti NLPI, Sugiartanti D, Putri R, Andriani, Nuradji H, Robinson M, Wiendayanthi N, Djufri F.Tarigan S, et al.PLoS One. 2023 Jan 20;18(1):e0280627. doi: 10.1371/journal.pone.0280627. eCollection 2023.PLoS One. 2023.PMID:36662754Free PMC article.
- A Spike Protein-Based Subunit SARS-CoV-2 Vaccine for Pets: Safety, Immunogenicity, and Protective Efficacy in Juvenile Cats.Tabynov K, Orynbassar M, Yelchibayeva L, Turebekov N, Yerubayev T, Matikhan N, Yespolov T, Petrovsky N, Tabynov K.Tabynov K, et al.Front Vet Sci. 2022 Mar 14;9:815978. doi: 10.3389/fvets.2022.815978. eCollection 2022.Front Vet Sci. 2022.PMID:35372556Free PMC article.
- SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States.Thomas E, Delabat S, Carattini YL, Andrews DM.Thomas E, et al.Viruses. 2021 Dec 13;13(12):2492. doi: 10.3390/v13122492.Viruses. 2021.PMID:34960762Free PMC article.Review.
- Variants of SARS-CoV-2: Influences on the Vaccines' Effectiveness and Possible Strategies to Overcome Their Consequences.Rabaan AA, Al-Ahmed SH, Albayat H, Alwarthan S, Alhajri M, Najim MA, AlShehail BM, Al-Adsani W, Alghadeer A, Abduljabbar WA, Alotaibi N, Alsalman J, Gorab AH, Almaghrabi RS, Zaidan AA, Aldossary S, Alissa M, Alburaiky LM, Alsalim FM, Thakur N, Verma G, Dhawan M.Rabaan AA, et al.Medicina (Kaunas). 2023 Mar 5;59(3):507. doi: 10.3390/medicina59030507.Medicina (Kaunas). 2023.PMID:36984508Free PMC article.Review.
- A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.Hu Z, Chen JP, Xu JC, Chen ZY, Qu R, Zhang L, Yao W, Wu J, Yang H, Lowrie DB, Liu Y, Fan XY.Hu Z, et al.Virology. 2022 Jan;566:56-59. doi: 10.1016/j.virol.2021.11.011. Epub 2021 Dec 1.Virology. 2022.PMID:34864488Free PMC article.
References
- Coronavirus disease 2019. World Heal Organ. 2020.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous